New HIV drug combo for kids shows promise in african study
Disease control
Completed
This study tested whether a new combination of three HIV medicines (dolutegravir, emtricitabine, and tenofovir alafenamide) at a special dose works well and is safe for children living with HIV in Africa. 53 children aged 28 days to 10 years took part. The goal is to create a sin…
Phase: PHASE2 • Sponsor: PENTA Foundation • Aim: Disease control
Last updated May 14, 2026 12:03 UTC